Market overview The leukemia therapeutics market size was valued at USD 16.63 billion in 2024. The market is projected to grow from USD 17.68 billion in 2025 to USD 31.43 billion by 2034, exhibiting a CAGR of 6.6% during the forecast period.  Leukemia — a heterogeneous group of hematologic malignancies including acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML),...